Content provided in partnership with

Business Services Industry

OBS Medical Appoints Chief Medical Officer to Strengthen Pharmaceutical Cardiac Safety Solutions

Business Wire, April 30, 2008

CARMEL, Ind. -- OBS Medical today announced the appointment of Jay W. Mason, M.D. as Chief Medical Officer.

Dr. Jay Mason, a renowned and respected expert in the field of cardiology, will work closely with the OBS Medical research team on innovative clinical algorithms for safer hospitals, safer patients and safer drugs. In this capacity, Dr. Mason will support worldwide pharmaceutical and biotech clients on cardiac safety. He will also continue his independent consultative practice.

Most Popular Articles in Business: Research and Markets : Tesco Plc - SWOT Framework Analysis; Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors; eBay made easy: ready to start an eBay business? These 5 simple steps will ...; Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...; Wal-Mart's newest distribution center opened last month near the southwest ...; More »

"We are excited to continue and expand our collaboration with Dr. Mason," said Frank Cheng, President and CEO of OBS Medical. "Dr. Mason brings a depth of knowledge and insight to improving the methodology used to assess the cardiac safety of new drugs. OBS has enjoyed an excellent and close professional relationship with Dr. Mason over the past years during which he has been instrumental in the development of our BioQT[TM] ECG Analytical Solutions. With his help we are poised to take our cardiac safety solutions to the next level."

Dr. Mason joins OBS Medical after serving as Medical Director and Director of Research and Development at Covance Cardiac Safety Services from April 2003 to April 2007. Dr. Mason's career began with graduation from Princeton University and the University of Pennsylvania, where he obtained his medical degree. He trained in Medicine and Cardiovascular Diseases at Stanford University Medical Center, where he was a member of the faculty from 1975 to 1983 and served as Director of the Cardiac Arrhythmia Service and Co-Director of the Cardiac Catheterization Laboratories. He became Chief of Cardiology and the University of Utah in 1983, where he was Primary Investigator of two major NIH-funded international clinical trials and an NIH-funded Specialized Center of Research in Sudden Death. In 1999, Dr. Mason was appointed Chairman of the Department of Medicine at the University of Kentucky. He remains a faculty member at the latter two institutions. Dr. Mason is the author of over 400 publications and is frequently invited to present on topics related to cardiac arrhythmias and electrophysiology.

About OBS Medical

OBS Medical is based in Carmel, Indiana and provides innovative clinical algorithms for safer hospitals, safer patients and safer drugs. Based on intelligent algorithms such as neural networks, data fusion and ECG waveform recognition, OBS Medical technologies cover a range of medical applications including automated early crisis warning (Visensia[TM]), automated assessment of ECG waveforms including QT interval measurement and morphology tracking (BioQT[TM]), and EEG analysis for brain-state assessment. OBS Medical is a wholly-owned subsidiary of Oxford BioSignals Ltd. based in Oxford, UK, which was originally spun out from Oxford University.

Business Services Industry

OBS Medical Appoints Chief Medical Officer to Strengthen Pharmaceutical Cardiac Safety Solutions

Business Wire, April 30, 2008

Find Research Guides for:

Find Featured Titles for: Home & Garden

Most Popular Articles in Business

Most Popular Publications in Business